Fluorogenic enzyme-linked immunosorbent assay with a dual color variation

Hanool Yun1, Hee-Jin Jeong1

  • 1Department of Biological and Chemical Engineering, Hongik University, 2639 Sejong-ro, Sejong-si 30016, South Korea.

Insights

A new fluorogenic enzyme-linked immunosorbent assay (FELISA) enables sensitive detection of tumor necrosis factor alpha (TNFα) and programmed cell death-ligand 1 (PDL1). This high-throughput method offers rapid and accurate biomarker analysis for disease diagnosis and treatment.

Area of Science:

  • Biochemistry
  • Immunology
  • Assay Development

Background:

  • Accurate biomarker detection is vital for disease diagnosis, monitoring, and treatment.
  • Existing immunoassay tools may lack the required sensitivity or throughput for certain applications.

Purpose of the Study:

  • To develop a sensitive and high-throughput fluorogenic enzyme-linked immunosorbent assay (FELISA).
  • To detect key biomarkers: tumor necrosis factor alpha (TNFα) and programmed cell death-ligand 1 (PDL1).

Main Methods:

  • Development of a FELISA utilizing Amplex Red or QuantaBlu fluorescent substrates.
  • Application of the assay for the detection of TNFα and PDL1.

Main Results:

  • Achieved a limit of detection in the nanogram order for TNFα and PDL1.
  • Enabled convenient assaying of multiple samples within 20 hours.
  • Demonstrated FELISA's applicability as a powerful immunoassay tool.

Conclusions:

  • FELISA provides a rapid and accurate method for detecting TNFα and PDL1.
  • This assay platform is versatile and can be adapted for various fluorogenic immunoassays against other antigens.

Related Concept Videos